Blueprint Medicines shares owned by De Lisle Partners
Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by De Lisle Partners
from 13F filings
Historical chart of De Lisle Partners investment in Blueprint Medicines
Tip: Access up to 7 years of quarterly data
All positions including Blueprint Medicines held by De Lisle Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Blueprint Medicines by De Lisle Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $539k | 5.0k | 107.87 |